NYSE American - Delayed Quote USD

Theriva Biologics, Inc. (TOVX)

Compare
1.1400 -0.0100 (-0.87%)
At close: December 20 at 4:00:00 PM EST
1.2100 +0.07 (+6.14%)
After hours: December 20 at 7:44:46 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 23.18k
Earnings -7.73M
Q4'23
Q1'24
Q2'24
Q3'24
-8M
-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

6.00
90.50 Average
1.1400 Current
175.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1--1--
Avg. Estimate -5.50-23.750
Low Estimate -5.50-23.750
High Estimate -5.50-23.750
Year Ago EPS -8.25-7.5-28.5--

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1--11
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) 0.00%--0.00%0.00%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -8.25-8.5-4.75-5.25
EPS Actual -8.25-7.5-10.75-6.81
Difference 01-6-1.56
Surprise % 0.00%11.76%-126.32%-29.71%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -5.50-23.750
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 1------
Up Last 30 Days 1------
Down Last 7 Days ----1--
Down Last 30 Days ----1--

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
TOVX 33.33%--16.67%--
S&P 500 5.00%12.00%2.10%12.20%

Upgrades & Downgrades

Maintains Maxim Group: Buy to Buy 11/13/2024

Related Tickers